Solasta Ventures, Inc. (formerly known in the U.S. as Aju IB Investment) is a wholly-owned subsidiary of Aju IB Investment, a leading South Korean venture capital firm.

We are committed to investing in innovative companies that advance the standard of care for diseases with unmet medical needs. Our team leverages deep scientific expertise and an extensive network to identify promising therapeutics and discovery platforms that have the potential to transform patients’ lives worldwide.

Tibit Communications

Seer

Rallybio

Rapt Therapeutics

Kezar Life Sciences

Kymera Therapeutics

Carisma Therapeutics

Xilio Therapeutics, Inc.

Apellis Pharmaceuticals

Arcellx

Atea Pharmaceuticals

Solasta Ventures

Viewport Meta

Euro

Google Font API

Content Delivery Network

Pound Sterling

Typekit

LocalBusiness Schema

Squarespace

President & CEO

Derek Yoon

Managing Partner, Silicon Valley

Michael Jeon

Legal

Michelle Levine, Ph.D.

Finance and Administration

Nia Julian

Executive Assistant

William Hahn

Chair & Scientific Advisory Board

Managing Partner

Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Atea Pharmaceuticals focuses on the discovery and development of next-generation therapeutics for severe human viral infections.

TiBiT Communications offers a disruptive technology that will fundamentally change the way broadband access.

Rapt  is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Venture Capital Investors (Top 10K)

Investors Active in Texas

Venture Capital Investors with Investments in South San Francisco, California

Early Stage Venture Investors with Investments in Redwood City, California

Solasta Ventures is investing in healthcare and life sciences for a brighter future.

Boston

Massachusetts

United States

North America

Axonis Therapeutics: $115 Million (Series A) Raised To Develop Novel Neuromedicines

Axonis Therapeutics Announces $115M Series A Financing

Axonis Therapeutics bags $115m for neuromedicine development

Axonis Therapeutics Raises $115M in Series A Financing

Axonis Therapeutics Announces $115 Million Series A Financing

Iceland

Europe

India

Asia

The Column Group LLC is a venture capital firm that invests in early-stage life sciences companies.

The Column Group LLC

Cellectar Biosciences is a biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer.

Cellectar Biosciences

Boehringer is a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing new medications of high therapeutic value for human and veterinary medicine.

Boehringer

Solasta Ventures is a venture capital firm that specializes in investing in early-stage technology startups. The firm focuses on companies that are developing breakthrough scientific solutions and disruptive technologies in various sectors such as artificial intelligence, life sciences, and sustainable energy.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 16, 2024 1:32 PM	c84d64e6
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	5549dd05
crunchbase profile	general	Nov 25, 2024 11:08 AM	a4e083c9
li profile	general	May 16, 2024 1:32 PM	b1c629d3
translate crunchbase fundingrounds	general	Nov 25, 2024 2:12 PM	0be7996d
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SOLASTA-VENTURES

Solasta Ventures